Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease

Lancet Gastroenterol Hepatol. 2021 Dec;6(12):987-988. doi: 10.1016/S2468-1253(21)00374-5. Epub 2021 Oct 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / complications
  • COVID-19 / immunology*
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / administration & dosage*
  • Child
  • Humans
  • Immunization Schedule
  • Immunization, Secondary / methods*
  • Immunization, Secondary / standards
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / immunology*
  • Middle Aged
  • Practice Guidelines as Topic
  • United Kingdom
  • Young Adult

Substances

  • COVID-19 Vaccines
  • Immunosuppressive Agents